NextPlat Corp
NXPL0.720USD
+0.031+4.47%
Horarios del mercado （ET）Cotizaciones retrasadas 15 min
18.70MCap. mercado
PérdidaP/E TTM
Más Datos de NextPlat Corp Compañía
NextPlat Corp is a global e-commerce and healthcare company. Its e-Commerce Operations segment involves acquiring and leasing, an e-commerce platform to collaborate with businesses to optimize their ability to sell their goods online, domestically, and internationally, and enabling customers and partners to optimize their e-commerce presence and revenue, and other related businesses. Its Healthcare Operations segment provides third-party administration, data management, COVID-19 related diagnostics and vaccinations, prescription pharmaceuticals, compounded medications, tele pharmacy services, anti-retroviral medications, medication therapy management, the supply of prescription medications to long-term care facilities, medication adherence packaging, contracted pharmacy services for 340B covered entities. It provides Mobile Satellite Services solutions for satellite-enabled voice, data, personnel and asset tracking, Machine-to-Machine and Internet of Things connectivity services.
Información de la empresa
Símbolo de cotizaciónNXPL
Nombre de la empresaNextPlat Corp
Fecha de salida a bolsaMar 15, 1999
Director ejecutivoMr. David Phipps
Número de empleados162
Tipo de seguridadOrdinary Share
Fin del año fiscalMar 15
Dirección3250 Mary St
CiudadCOCONUT GROVE
Bolsa de valoresNASDAQ Capital Market Consolidated
PaísUnited States of America
Código postal33133
Teléfono13055605355
Sitio Webhttps://ir.nextplat.com/
Símbolo de cotizaciónNXPL
Fecha de salida a bolsaMar 15, 1999
Director ejecutivoMr. David Phipps
Ejecutivos de la empresa
Nombre
Nombre/Posición
Posición
Accionistas
Cambio
Mr. Rodney Barreto
Mr. Rodney Barreto
Non-Executive Independent Chairman of the Board
Non-Executive Independent Chairman of the Board
2.24M
+36.14%
Mr. David Phipps
Mr. David Phipps
President, Interim Chief Executive Officer, Director, Chief Executive Officer - Global Operations
President, Interim Chief Executive Officer, Director, Chief Executive Officer - Global Operations
421.79K
--
Ms. Elizabeth Alcaine
Ms. Elizabeth Alcaine
Independent Director
Independent Director
60.57K
--
Mr. Anthony Armas
Mr. Anthony Armas
Independent Director
Independent Director
60.57K
--
Mr. Louis Cusimano
Mr. Louis Cusimano
Independent Director
Independent Director
35.43K
-36.08%
Mr. Hector Delgado
Mr. Hector Delgado
Independent Director
Independent Director
24.60K
--
Ms. Cecile Munnik
Ms. Cecile Munnik
Chief Financial Officer
Chief Financial Officer
12.43K
--
Mr. Douglas S. Ellenoff
Mr. Douglas S. Ellenoff
Vice Chairman of the Board, Chief Business Development Strategist
Vice Chairman of the Board, Chief Business Development Strategist
--
--
Mr. Robert Bedwell
Mr. Robert Bedwell
Chief Compliance Officer
Chief Compliance Officer
--
--
Mr. Michael Glickman
Mr. Michael Glickman
Investor Relations
Investor Relations
--
--
Nombre
Nombre/Posición
Posición
Accionistas
Cambio
Mr. Rodney Barreto
Mr. Rodney Barreto
Non-Executive Independent Chairman of the Board
Non-Executive Independent Chairman of the Board
2.24M
+36.14%
Mr. David Phipps
Mr. David Phipps
President, Interim Chief Executive Officer, Director, Chief Executive Officer - Global Operations
President, Interim Chief Executive Officer, Director, Chief Executive Officer - Global Operations
421.79K
--
Ms. Elizabeth Alcaine
Ms. Elizabeth Alcaine
Independent Director
Independent Director
60.57K
--
Mr. Anthony Armas
Mr. Anthony Armas
Independent Director
Independent Director
60.57K
--
Mr. Louis Cusimano
Mr. Louis Cusimano
Independent Director
Independent Director
35.43K
-36.08%
Mr. Hector Delgado
Mr. Hector Delgado
Independent Director
Independent Director
24.60K
--
Desglose de ingresos
Divisa: USDActualizado: dom., 6 de jul
Divisa: USDActualizado: dom., 6 de jul
FY2025Q1
FY2024
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022
FY2022Q4
FY2022Q3
FY2022Q2
FY2022Q1
FY2021
Por negocioUSD
Nombre
Ganancia
Proporción
Pharmacy Prescription And Other Revenue Net Of Pbm Fees
10.09M
69.47%
e-Commerce revenue
3.01M
20.70%
Pharmacy 340B contract revenue
1.43M
47.54%
Por regiónUSD
Nombre
Ganancia
Proporción
Europe
1.57M
52.33%
North America
1.03M
34.36%
Asia & Pacific
348.00K
11.58%
Africa
44.00K
1.46%
South America
8.00K
0.27%
Por negocio
Por región
Por negocioUSD
Nombre
Ganancia
Proporción
Pharmacy Prescription And Other Revenue Net Of Pbm Fees
10.09M
69.47%
e-Commerce revenue
3.01M
20.70%
Pharmacy 340B contract revenue
1.43M
47.54%
Estadísticas de accionistas
Actualizado: sáb., 17 de may
Actualizado: sáb., 17 de may
Accionistas
Tipos de accionistas
Accionistas
Accionistas
Proporción
Fernandez (Charles M)
17.69%
Frost Gamma Investments Trust
13.21%
Barreto (Rodney)
8.63%
Keyser (Robert)
3.77%
EverSource Wealth Advisors, LLC
2.24%
Other
54.47%
Accionistas
Accionistas
Proporción
Fernandez (Charles M)
17.69%
Frost Gamma Investments Trust
13.21%
Barreto (Rodney)
8.63%
Keyser (Robert)
3.77%
EverSource Wealth Advisors, LLC
2.24%
Other
54.47%
Tipos de accionistas
Accionistas
Proporción
Individual Investor
33.45%
Corporation
13.21%
Investment Advisor
3.02%
Investment Advisor/Hedge Fund
1.01%
Hedge Fund
0.33%
Research Firm
0.04%
Other
48.95%
Participación institucional
Actualizado: mar., 1 de jul
Actualizado: mar., 1 de jul
Periodo del informe
Número de instituciones
Acciones mantenidas
Proporción
Cambio
2025Q2
43
13.25M
51.05%
+1.70M
2025Q1
43
11.85M
60.63%
+595.42K
2024Q4
41
12.22M
47.07%
+1.42M
2024Q3
33
11.44M
52.41%
+839.72K
2024Q2
34
11.11M
57.81%
+518.97K
2024Q1
35
11.08M
58.38%
+876.45K
2023Q4
35
10.68M
71.96%
+7.69M
2023Q3
37
11.28M
76.50%
+7.16M
2023Q2
40
11.24M
76.32%
+7.16M
2023Q1
32
3.94M
34.49%
-72.05K
Ver más
Actividad de los accionistas
Nombre
Acciones mantenidas
Proporción
Cambio
Cambio %
Fecha
Fernandez (Charles M)
4.59M
17.69%
+687.04K
+17.59%
Apr 28, 2025
Frost Gamma Investments Trust
3.43M
13.21%
--
--
Apr 28, 2025
Barreto (Rodney)
2.24M
8.63%
+594.49K
+36.14%
Apr 28, 2025
Keyser (Robert)
979.50K
3.77%
+78.75K
+8.74%
Apr 28, 2025
EverSource Wealth Advisors, LLC
580.69K
2.24%
+137.30K
+30.97%
Mar 31, 2025
Phipps (David)
421.79K
1.62%
--
--
Apr 28, 2025
Geode Capital Management, L.L.C.
217.43K
0.84%
+51.97K
+31.41%
Mar 31, 2025
Hough (Jervis Bennett)
127.67K
0.49%
+127.67K
--
Oct 01, 2024
Ellenoff (Douglas S.)
125.00K
0.48%
--
--
Apr 28, 2025
Omnia Family Wealth, LLC
90.23K
0.35%
-3.20K
-3.43%
Mar 31, 2025
Ver más
ETFs relacionados
Actualizado: sáb., 2 de ago
Actualizado: sáb., 2 de ago
Nombre
Proporción
iShares Micro-Cap ETF
0%
Fidelity Nasdaq Composite Index ETF
0%
Dimensional US Core Equity 1 ETF
0%
iShares Micro-Cap ETF
Proporción0%
Fidelity Nasdaq Composite Index ETF
Proporción0%
Dimensional US Core Equity 1 ETF
Proporción0%
Dividendos
Un total de
0.00
USD se ha distribuido en dividendos durante los últimos 5 años.
Fecha
Dividendos
Fecha de registro
Fecha de pago
Fecha ex-dividendo
Sin datos
División de acciones
Fecha
Tipo
Relación
Sin datos
Fecha
Tipo
Relación
Sin datos
